Intalight – Light Every Sight2024-02-22T16:48:14+08:00

Light Every Sight

Intalight was founded by a group of scientists and industry veterans of Silicon Valley in 2014 with a core mission to develop the most advanced ophthalmic technologies. In 2015, the company’s base of operations moved to mainland China, and there are now three sites in Silicon Valley, Shanghai, and Luoyang.

In 2019, Intalight released the first Swept-Source Optical Coherence Tomography (OCT) device that combines Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities, abbreviated as DREAM OCT™.

The powerful imaging device has become an indispensable tool for many ophthalmologists in not only their daily clinical use but also their exploration of the research frontiers. To date, over 100 papers have been published in peer-reviewed journals based on the findings using DREAM OCT™ devices.

Intalight will continue the innovation and push the limit of technologies. The product portfolios are extending from ophthalmic diagnostic devices to operational instruments. In doing so, Intalight aims to empower ophthalmologists and benefit the patients worldwide.

Light Every Sight

Intalight was founded by a group of scientists and industry veterans of Silicon Valley in 2014 with a core mission to develop the most advanced ophthalmic technologies. In 2015, the company’s base of operations moved to mainland China, and there are now three sites in Silicon Valley, Shanghai, and Luoyang.

In 2019, Intalight released the first Swept-Source Optical Coherence Tomography (OCT) device that combines Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities, abbreviated as DREAM OCT™.

The powerful imaging device has become an indispensable tool for many ophthalmologists in not only their daily clinical use but also their exploration of the research frontiers. To date, over 100 papers have been published in peer-reviewed journals based on the findings using DREAM OCT™ devices.

Intalight will continue the innovation and push the limit of technologies. The product portfolios are extending from ophthalmic diagnostic devices to operational instruments. In doing so, Intalight aims to empower ophthalmologists and benefit the patients worldwide.

Exploring the Whole Eye

DREAM OCT

Deep  |  Rapid  |  Extensive  |  Accurate  |  Multimodal

*DREAM OCT is pending FDA approval.

*DREAM OCT is not yet available for sale in the US.

Exploring the Whole Eye

DREAM OCT

Deep | Rapid | Extensive | Accurate | Multimodal

*DREAM OCT is pending FDA approval.

*DREAM OCT is not yet available for sale in the US.

News

Intalight Symposium at the ICOOR 2023 in Rome

News

Intalight Symposium at the ICOOR 2023 in Rome

Contact

Silicon Valley Office

  • 160 E Tasman Drive, Suite 107, San Jose, CA 95134, USA

  • +1 (408) 520-3557

Shanghai Office

  • 3F, 939 Haining Road, Shanghai, 200085, China

  • +86 400-0379-805

Luoyang Office

  • 2 Penglai Road, Bldg 3A-1F, National University Science and Technology Park, Luoyang, Henan 471003, China

  • +86 400-0379-805

  • info@intalight.com

Contact

Silicon Valley Office

  • 160 E Tasman Drive, Suite 107, San Jose, CA 95134, USA

  • +1 (408) 520-3557

Shanghai Office

  • 899 Haining Road, Bldg A, Suite 702A, Shanghai 200085, China

  • +86 400-0379-805

Luoyang Office

  • 2 Penglai Road, Bldg 3A-1F, National University Science and Technology Park, Luoyang, Henan 471003, China

  • +86 400-0379-805

  • info@intalight.com

Go to Top